MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. PRCT
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

PROCEPT BioRobotics (PRCT) Financial Metrics 2021-2026

Key metrics and charts across all fundamental categories.

Prices

Stock price and market valuation

Stock Price
$19.35
66.4%
Market Cap
$1.10B
65.4%

PRCT trades at $19.35, a 66.4% decrease year-over-year. Market capitalization stands at $1.10B, down 65.4% from the prior year. Track PRCT price trends and market cap history to understand how the market values this company over time.

Stock Price
How the market values the company over time
Market Cap
Total equity value as determined by the market

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$337.34M
22.7%
Q. Revenue
$94.50M
TTM EBITDA
$-107.18M
24.7%
TTM Op. Income
$-114.23M
24.5%
Q. Op. Income
$-27.39M
TTM Net Income
$-109.76M
30.4%
Q. Net Income
$-26.86M
EPS
$-0.47
Shares Out.
$57.07M
2.9%
$337.34M in TTM revenue grew 22.7% YoY, reaching $94.50M last quarter. TTM EBITDA of $-107.18M and TTM operating income of $-114.23M show growth is flowing through to the bottom line. However, net income is negative at $109.76M — growth is not yet reaching the bottom line.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders

Assets & Liabilities

Assets, cash, debt, book value, and leverage

Total Assets
$479.35M
Cash
$227.91M
Long-Term Debt
$51.72M
Book Value
$340.07M
D/E Ratio
0.2
Debt/EBITDA
N/A
With $479.35M in assets and $51.72M in long-term debt, D/E is 0.2and book value is $340.07M — a conservative capital structure with a cushion to weather downturns.
Total Assets
Expanding asset base can indicate business growth
Cash & Equivalents
Shows liquidity available for opportunities or downturns
Long-Term Debt
Declining debt trend is generally positive
Book Value (Equity)
Growing book value signals intrinsic value creation
Debt / Equity
Lower means less reliance on borrowed money
Debt / EBITDA
Below 2x is conservative; above 4x is high

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$-19.25M
TTM Free Cash Flow
$-84.92M
4.9%
FCF Margin
-25.2%
FCF / Net Income
0.8
TTM FCF of $-84.92M on $-19.25M in operating cash flow. The FCF / Net Income ratio of 0.8x means free cash flow covers net income — earnings are backed by cash.
Operating Cash Flow
Cash generated from core business operations
Free Cash Flow
Cash the business generates after maintaining itself
FCF Margin (TTM %)
TTM FCF / TTM Revenue — 10%+ signals a capital-efficient business model
FCF / Net Income (TTM)
TTM FCF / TTM Net Income — above 1 means earnings are backed by real cash

Margins

Profit margins across the income statement

Gross Margin
66.0%
1.0%
EBITDA Margin
-26.9%
Op. Margin
-29.0%
3.4%
Net Margin
-28.4%
15.0%
Op. margin of -29.0% is down 1.0% YoY — costs are rising relative to revenue. Net margin at -28.4% and gross margin of 66.0% show how much of each revenue dollar survives to profit.
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit

Price Ratios

Valuation multiples — is the company cheap or expensive?

P/E Ratio
N/A
P/S Ratio
3.3x
P/B Ratio
3.2x
P/S of 3.3x and P/B of 3.2x.
P/E Ratio
Higher suggests growth expectations; lower may signal undervaluation
P/S Ratio
Useful when earnings are volatile or negative
P/B Ratio
Below 1 means trading below accounting book value
EV / EBITDA
Lower multiple often signals better value
FCF Yield (TTM %)
TTM FCF / Market Cap — compare to bond yields
Earnings Yield (%)
Earnings return at current price — inverse of P/E

Others

Return ratios, efficiency, and credit metrics

ROE
-32.3%
ROA
-22.9%
Asset Turnover
0.7
Rev/Share
$5.91
ROA of -22.9% shows how efficiently management uses assets to generate profit. Revenue per share at $5.911 removes dilution effects from top-line growth.
Return on Equity (ROE)
15%+ consistently signals a durable competitive advantage
Return on Assets (ROA)
How well management uses assets to generate profit
Asset Turnover
How efficiently assets generate each dollar of sales
Revenue per Share
Per-share revenue growth adjusted for dilution
Interest Coverage
How comfortably the company covers interest payments